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biochemical and physiological properties of the transferrins. Because
of the large body of knowledge contributed by Phil and his laboratory
over so many years, his name has become synonymous with transfer-
rin. The history of transferrin itself began in 1945 when Swedish bio-
chemists C. G. Holmberg and C. B. Laurall reported on a high
molecular weight iron-binding component in porcine serum. They
discovered this component almost by accident during studies of
serum copper. Two years later they demonstrated that this pink com-
ponent was a protein of molecular weight c.a. 88,000 which bound
two iron atoms but also bound copper. They correctly predicted that
it was a carrier of iron, naming it “transferrin” after its iron transport
and transferring properties. They also demonstrated that, while cop-
per binds to transferrin, it preferentially binds to other serum pro-
teins and that in serum, transferrin itself is devoid of copper.
In the early 1960s after completing his residency in internal med-
icine, Phil Aisen began working on the copper centers of ceruloplas-
min. At the time, he was one of the early investigators in the
developing ﬁeld of metallobiochemistry. He published a series of pa-
pers on ceruloplasmin in the JBC and Nature. However, his research
interests soon shifted to iron and, in 1966, he published his ﬁrst
paper on transferrin in the JBC entitled “Studies on the binding of
iron to transferrin and conalbumin”. This work was soon followed
by a large number of papers on the physicochemical properties of
the transferrins. In those early days, Phil was the ﬁrst to show that
transferrin also binds chromium, cobalt and manganese in addition
to iron and copper. Forty-two years and many investigations later,
we now know that the protein binds virtually all transition metals
and many of the lanthanides.0304-4165 © 2012 Elsevier B.V.
doi:10.1016/j.bbagen.2012.01.010
Open access under CC BY-NC-ND license. The obligate requirement of (bi)carbonate binding for iron bind-
ing is one of the unique aspects of transferrin chemistry. Phil under-
took one of the ﬁrst studies of the anion binding properties of
transferrin with collaborators Roland Aasa and Tore Vänngård while
on a Guggenheim fellowship during 1966–1967 in the lab of Bo Mal-
mström. In 1967 they conﬁrmed that (bi)carbonate binding was re-
quired for metal binding but that other suitable anions could also
serve this purpose. Phil correctly predicted that the anion probably
served as a linkage between the protein and metal, a prediction
borne out by the crystal structure of lactoferrin published some
20 years later by Ted Baker and colleagues. It was in Gothenburg,
Sweden, in Malmström's lab that Phil also learned EPR, a spectroscop-
ic method which he later employed with great effectiveness through-
out his career to extract information about the metal binding sites of
the transferrins but of other proteins as well. From the large body of
early work, Phil became the acknowledged authority on transferrin.
Phil has always been a strong advocate for fundamental studies of
the role of iron in biology. With Pauline Harrison and Ernie Huehns,
he jointly organized the ﬁrst conference on Proteins of Iron Storage
and Transport which was held in London in 1973. That ﬁrst meeting
was devoted exclusively to transferrin and ferritin, the key players
in iron metabolism known at the time. This iron meeting became a bi-
annual event. It eventually covered all aspects of iron metabolism as
new information regarding mechanisms of iron homeostasis became
available and new players were discovered. Over the years this con-
ference has grown enormously in attendance. The formation of the
International BioIron Society (IBIS) many years later was an out-
growth of these meetings. The IBIS continues to grow and ﬂourish,
holding biannual meetings throughout the world, traced back to
that ﬁrst meeting in 1973.
During the 1970's, much interest centered on the Fletcher–
Huehns hypothesis concerning the physiological role of the two iron
binding sites in the mechanism of iron transport. A key question at
the time was whether the two metal binding sites of transferrin
were structurally and functionally distinct. A classic JBC paper in
1978 by Leibman, Zweier and Aisen reported the four microscopic
site binding constants for transferrin as measured by equilibrium di-
alysis and urea-gel electrophoresis to separate and quantify the four
species of transferrin. This work unequivocally demonstrated that
the two sites have different afﬁnities for iron and that the occupancy
of one site inﬂuenced the iron binding strength of the other despite
the fact that the sites are located some 45 Å apart in separate lobes
of the protein. This thermodynamic study, while a major advance it-
self, also laid the framework for thinking about the kinetics of iron re-
lease from transferrin. Four microscopic rate constants would also be
required to describe the dynamics of this system.
The Aisen lab went on to address the kinetics of iron release from
the protein by physiological chelators, ultimately studying the role of
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the early studies of Evan Morgan, who ﬁrst showed that transferrin
bound to its receptor is internalized within the cell, and the later
work of the Lodish and Klausner groups deciphering many of the de-
tails of this process. The Aisen lab developed methods for obtaining
the C-lobe half transferrin and initiated studies of the effects of the in-
dividual lobes on the binding of the protein to its receptor. They ﬁrst
demonstrated that iron is preferentially released from the C-lobe at
the endosomal pH~5.6, a ﬁnding in marked contrast to the behavior
of the protein in the absence of the receptor. Thus the receptor was
shown to modulate the release of iron from transferrin as well as to
serve as a carrier of the iron laden protein into the cell. This seminal
work helped to lay the foundation for further work on transferrin-
receptor binding and iron release kinetics subsequently carried out
in other laboratories and led to many lively debates in the literature
on the respective roles of the two lobes in these processes.
In the intervening years, Phil also worked in a number of other im-
portant research areas, including iron uptake from transferrin and
ferritin by liver Kupffer cells. Phil and coworkers demonstrated that,
in the presence of iron, ascorbate generated radical species leading
to cell death, a ﬁnding of relevance to the toxicity of ascorbate in
iron overload disease. He also published a series of seminal papers
on uteroferrin, a purple acid phosphatase isolated from the amniotic
ﬂuid of porcine pregnancies. He demonstrated that the diiron center
redox cycles between the purple ferric and pink ferrous form and
that the latter is the enzymatically active form.
Phil has published some 200 articles, spanning 55 years of re-
search activity well past the normal age of retirement. His most re-
cent paper was published in 2010 in the JMB. His many
comprehensive reviews covering nearly all aspects of iron metabo-
lism have been valuable resources for the research community. Addi-
tionally, Phil has served on the editorial boards of Biometals,
Hepatology, Journal of Inorganic Biochemistry and Biochemical Jour-
nal and was chair of the Gordon Conferences on Metals in Biology
and on Magnetic Resonance in Biology and Medicine. He chaired the
Bioanalytical and Metallobiochemistry Study Section of the NIH and
was a frequent ad hoc member of special study sections. Phil was an
often sought-after member of review panels because of his breadth
of knowledge and ability to assess the intrinsic value of proposed re-
search. He set high standards, butwas always fair in his reviews, and of-
fered encouragement to young scientists. Hewas amentor tome and to
thosewhoworked in his lab orwere otherwise fortunate enough to col-
laborate with him and have the opportunity to learn from him.
Phil received his A.B. degree Phi Beta Kappa in Philosophy in 1949
and his M.D. degree from the Columbia College of Physicians and Sur-
geons. He completed internship and residencies at Mount Sinai Hos-
pital. In 1970, after three years as Manager of Biochemical Research
at the IBM Watson Laboratory at Columbia, he moved to the AlbertEinstein College of Medicine. Although most of Phil's research can
be broadly classiﬁed as biophysical/bioinorganic chemistry and cellu-
lar physiology of iron, he continued to see patients throughout much
of his research career. He felt that it was important to keep a hand in
the clinical side of medicine. His science was better for it.
What is particularly remarkable is the fact that Phil had limited
formal schooling in advanced mathematics, chemistry and physics
and yet his papers rely heavily on these subjects. He is largely self-
taught in these areas, possessing an in-depth knowledge of them
which is clearly reﬂected in his papers and the graduate courses he
has taught at Einstein. He has given courses in spectroscopy and
quantummechanics, biophysics and physical chemistry of macromol-
ecules, not the usual subjects taught by an M.D.. In his retirement,
Phil, ever seeking a challenge, has been teaching himself abstract al-
gebra by working his way through Hungerford's book, an endeavor
which helps to keep the mind sharp. Three of his grandchildren are
versed in advanced mathematics and occasionally lend a hand with
some of the more arcane proofs of abstract algebra as Phil grapples
with Galois theory, quarternions, cyclic groups, matrices of spin Ham-
iltonians and more than 100 theorems to date.
On a personal note, Phil met May at a summer camp in 1946. She
was a drama counselor and he was a nature counselor. They started
dating a year later and were married in August 1951. May and Phil
had two sons Alex and Paul, both physicians and researchers, and a
daughter Judith, an attorney. They have nine grandchildren, Benja-
min, Amanda, Daniel, Joshua, Adam, Ariel, Noah, Andrew and Samuel.
Son Alex is Professor of Radiology at Indiana University and Paul is a
Professor in the Department of Neurosciences at the University of Cal-
ifornia, San Diego. One comes away from a visit to the Aisen home
with a strong sense of family. The Aisens were frequently warm and
generous hosts for many a traveling scientist who stayed at their
home while visiting New York. Sadly, May passed away quite unex-
pectedly on February 1st, 2011. She was well known and beloved
among the iron community, frequently accompanying Phil on his
travels. May was a spunky lady with great wit and intellect and
much fun to be with. She is missed by all who knew her.
While Phil at the age of 82 no longer has an active research lab-
oratory, he retains a passionate interest in the biochemistry of
iron, science in general and medicine. When you are with Phil
you can always count on a lively conversation. That is still true
to this day. His many contributions have helped to lay the founda-
tion for much of the iron biochemistry currently being carried out
in laboratories throughout the world. The transferrin community
of scholars and indeed the ﬁeld of iron metabolism owe a great
deal to Philip Aisen. To him we dedicate this volume.
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